BR0107404A - Derivados de indol que atuam como antagonistas do receptor mcp-1 - Google Patents

Derivados de indol que atuam como antagonistas do receptor mcp-1

Info

Publication number
BR0107404A
BR0107404A BR0107404-0A BR0107404A BR0107404A BR 0107404 A BR0107404 A BR 0107404A BR 0107404 A BR0107404 A BR 0107404A BR 0107404 A BR0107404 A BR 0107404A
Authority
BR
Brazil
Prior art keywords
hydrogen
mcp
halogen
act
receptor antagonists
Prior art date
Application number
BR0107404-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Alan Wellington Faull
Jason Grant Kettle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0107404A publication Critical patent/BR0107404A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BR0107404-0A 2000-01-13 2001-01-11 Derivados de indol que atuam como antagonistas do receptor mcp-1 BR0107404A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000626.2A GB0000626D0 (en) 2000-01-13 2000-01-13 Chemical compounds
PCT/GB2001/000069 WO2001051466A1 (en) 2000-01-13 2001-01-11 Indole derivatives as mcp-1 receptor antagonists

Publications (1)

Publication Number Publication Date
BR0107404A true BR0107404A (pt) 2002-10-08

Family

ID=9883551

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107404-0A BR0107404A (pt) 2000-01-13 2001-01-11 Derivados de indol que atuam como antagonistas do receptor mcp-1

Country Status (25)

Country Link
US (1) US20030144339A1 (https=)
EP (1) EP1252142A1 (https=)
JP (1) JP2003519683A (https=)
KR (1) KR20020064375A (https=)
CN (1) CN1395565A (https=)
AR (1) AR026839A1 (https=)
AU (1) AU780992B2 (https=)
BG (1) BG106894A (https=)
BR (1) BR0107404A (https=)
CA (1) CA2393592A1 (https=)
CO (1) CO5271703A1 (https=)
EE (1) EE200200394A (https=)
GB (1) GB0000626D0 (https=)
HK (1) HK1049486A1 (https=)
HU (1) HUP0300694A3 (https=)
IL (1) IL150272A0 (https=)
IS (1) IS6429A (https=)
MX (1) MXPA02006611A (https=)
NO (1) NO20023380L (https=)
NZ (1) NZ519312A (https=)
PL (1) PL356031A1 (https=)
RU (1) RU2002121636A (https=)
SK (1) SK10072002A3 (https=)
WO (1) WO2001051466A1 (https=)
ZA (1) ZA200204354B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
AU2003215549A1 (en) 2003-02-03 2004-08-30 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
CN100566811C (zh) * 2004-09-13 2009-12-09 株式会社吴羽 热发泡性微球及其制造方法、其用途、含有其的组合物、和物品
DE602006010433D1 (de) 2005-12-09 2009-12-24 Hoffmann La Roche Für die behandlung von obesitas geeignete tricyclische amidderivate
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
US7507736B2 (en) 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
CA2951295C (en) 2007-04-16 2020-04-28 Abbvie Inc. 7-nonsubstituted indole mcl-1 inhibitors
WO2023224981A1 (en) * 2022-05-17 2023-11-23 Inipharm, Inc. Hsd17b13 inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529724A (en) * 1983-10-11 1985-07-16 Mcneilab, Inc. 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DE3907388A1 (de) * 1989-03-08 1990-09-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung von indolcarbonsaeurederivaten
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5081145A (en) * 1990-02-01 1992-01-14 Merck Frosst Canada, Inc. Indole-2-alkanoic acids compositions of and anti allergic use thereof
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5273980A (en) * 1991-09-30 1993-12-28 Merck Frosst Canada Inc. Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US5686481A (en) * 1993-12-21 1997-11-11 Smithkline Beecham Corporation Endothelin receptor antagonists
US5482960A (en) * 1994-11-14 1996-01-09 Warner-Lambert Company Nonpeptide endothelin antagonists
US5684032A (en) * 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
EP1021181A4 (en) * 1996-03-28 2002-06-26 Smithkline Beecham Corp INDOLCARBOXYLIC ACIDS AS CHEMOKIN INHIBITORS
WO1998006703A1 (en) * 1996-08-14 1998-02-19 Warner-Lambert Company 2-phenyl benzimidazole derivatives as mcp-1 antagonists
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9902461D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1395565A (zh) 2003-02-05
NO20023380L (no) 2002-09-03
IS6429A (is) 2002-06-19
HK1049486A1 (zh) 2003-05-16
EE200200394A (et) 2003-12-15
NZ519312A (en) 2004-04-30
RU2002121636A (ru) 2004-01-10
AR026839A1 (es) 2003-02-26
IL150272A0 (en) 2002-12-01
HUP0300694A2 (hu) 2003-07-28
CO5271703A1 (es) 2003-04-30
SK10072002A3 (sk) 2003-06-03
MXPA02006611A (es) 2002-09-30
AU2532401A (en) 2001-07-24
JP2003519683A (ja) 2003-06-24
CA2393592A1 (en) 2001-07-19
EP1252142A1 (en) 2002-10-30
AU780992B2 (en) 2005-04-28
KR20020064375A (ko) 2002-08-07
ZA200204354B (en) 2003-09-01
BG106894A (bg) 2003-04-30
WO2001051466A1 (en) 2001-07-19
NO20023380D0 (no) 2002-07-12
PL356031A1 (en) 2004-06-14
HUP0300694A3 (en) 2005-08-29
US20030144339A1 (en) 2003-07-31
GB0000626D0 (en) 2000-03-01

Similar Documents

Publication Publication Date Title
EA200500304A1 (ru) Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
JO2372B1 (en) Source drugs of 4-phenylpyridine derivatives
MY138352A (en) Benzothiazole derivatives
NO20075134L (no) Bestemte substituerte amider, fremgangsmate for femstilling derav og anvendelse derav
JO2282B1 (en) Oxazole derivatives
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
ATE485265T1 (de) 5-substituierte-2-phenylaminobenzamide als mek- inhibitoren
DE60224172D1 (de) Formanilid-derivative als beta2-adrenorezeptor-agonisten
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
NO20041631L (no) Piperazinderivater med CCR1 reseptor antagonist
MA29213B1 (fr) Quinolones a substitution macrolones - amino
GB0413087D0 (en) Therapeutic compounds
WO2001064645A3 (en) Derivatives of quinoline as alpha-2 antagonists
EP0915094A4 (en) MORPHINANE DERIVATIVES AND MEDICAL USE THEREOF
BR0107404A (pt) Derivados de indol que atuam como antagonistas do receptor mcp-1
DE60031686D1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
MA30540B1 (fr) Derives de quinolines et compositions pharmaceutiques de ces derives.
EA201170150A1 (ru) Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсона
ATE386738T1 (de) Flavaxat-derivate als muscarin-rezeptor antagonisten
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
MX2007005199A (es) Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
IL160082A0 (en) Quinoline derivatives and use thereof as antitumor agents
JP2007507467A5 (https=)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.